This site uses cookies to offer you a better browsing experience. Find out more on how we use cookies.

 Closed

AviSense Platform

Avicenna Oncology has developed a proprietary platform for the scouting, evaluation and development of its innovative assets. AviSense® Platform is a fast, cost-effective and virtual platform enabling the out-licensing of Avicenna's technology in 18 to 24 months.

AviSense® Platform: